Cortisone Shots Market Research Report - Global Forecast till 2027

Cortisone Shots Market Information: By Type (Articular or Joint Injections, Epidural Steroid Injection, Trigger Point Injection), Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Tendinitis, Allergic Reaction), End User - Global Forecast till 2027

ID: MRFR/Pharma/3419-HCR | | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Intended Audience



  • Cortisone Injection Manufacturers

  • Cortisone Injection Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology
Cortisone Shots Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Market Synopsis of the Global Cortisone Shots Market


Also known as cortisone injections, cortisone shots are used to relieve pain and inflammation in case of injury to the joints or other parts of the body. They are most commonly used to treat inflammation at the joints such as knee, spine, ankle, elbow, hip, shoulder and wrist, and are usually administered in a clinical setting with the doctor’s approval. Cortisone injections have a similar anti-inflammatory action to other corticosteroids. It is composed of corticosteroid medication and a local anesthetic. Due to the potential side effects of cortisone shots, the number of doses administered to a patient is limited. Major indications for the use of cortisone shots are arthritis, skin diseases, tendinitis, and other sport injuries.


Rising prevalence of chronic diseases such as rheumatoid arthritis, tendinitis, and bursitis, increasing number of injuries to the joints, muscles and tendon, and the presence of key players in the market are important driver that accelerate the growth of the market. Rising geriatric population is another key driver for the market growth due to increasing prevalence of arthritis among the elderly. However, cortisone shots exhibit a number of disadvantages such as damage to the tendons, ligaments, and articular cartilage, thus restricting the growth of the market.


The global cortisone shots market is expected to grow at a CAGR of 5.2% during the forecast period. 


FIGURE 1: Global Cortisone Shots Market by Region, 2016 (%)
Global Cortisone Shots Market


Source: World Health Organization, Centers for Disease Control and Prevention (CDC), European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


Segments                                                                                                                                            


The global cortisone shots market is segmented on the basis of type, indication, and end user.


On the basis of type, market is segmented into articular or joint injections, epidural steroid injection, trigger point injection, and others.


On the basis of indication, the market is segmented into rheumatoid arthritis, psoriatic arthritis, bursitis, allergic reaction, skin conditions, and others.


On the basis of end user, the market is segmented into hospitals, clinics, sport medicine centers, pharmaceutical companies, and others.


Regional Analysis of the Global Cortisone Shots Market                     


America acquires the first position in the market for cortisone shots owing to the rising prevalence of various types of allergies, arthritis, tendinitis, and others, and rising demand for corticosteroid injection in the U.S. According to the Center for Disease Control and Prevention, an estimated 78 million i.e. 26% of the U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Additionally, the prevalence of tendinitis among athletes is found to be increasing from last few years in the U.S.


Europe is the second largest market for cortisone shots owing to the rising prevalence of rheumatoid arthritis in European countries, and availability of funds for research and development activities. Also, rising prevalence of allergic conditions such as asthma, food allergy, and anaphylaxis, increasing demand for diagnostic services and rising awareness about the use of cortisone injections for the treatment of tendinitis fuels the market growth.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising prevalence of diabetes, obesity, which act as risk factors for rheumatoid and osteoarthritis which is further posed to propel the growth of the market. Furthermore, rising awareness about sport injuries and the use of cortisone shots for their treatment, influences the growth of the market positively.


The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic diseases such as obesity and diabetes, and improving healthcare infrastructure. Increasing demand for new treatment options for sport injuries also influences the market growth in the Middle East & African countries.


Key Players in the Global Cortisone Shots Market       


Some of the key players in this market are Merck & Co., Inc. (U.S.), Pfizer (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Germany), GlaxoSmithKline (U.S.), Pharmascience Inc. (U.S.), Farmabios SPA (Italy), AdvaCare Pharma (U.S.), and others.



Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment


5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Cortisone shots Market, by Type

6.1 Introduction

6.2 Articular or Joint Injection

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Epidural Steroid Injection

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Trigger Point" Injection

6.4.1 Market Estimates & Forecast, 2020-2027

7. Global Cortisone shots Market, by Indication

7.1 Introduction

7.2 Rheumatoid Arthritis

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Psoriatic Arthritis

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Bursitis

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Tendinitis

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Allergic Reaction

7.6.1 Market Estimates & Forecast, 2020-2027

7.7 Skin Conditions

7.7.1 Market Estimates & Forecast, 2020-2027

8. Global Cortisone shots Market, by End User

8.1 Introduction

8.2 Hospital

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Clinics

8.3.1 Market Estimates & Forecast, 2020-2027

8.3 Sport Medicine Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Pharmaceutical Companies

8.4.1 Market Estimates & Forecast, 2020-2027

9. Global Cortisone shots Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 UK

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Merck & Co., Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Pfizer

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bristol-Myers Squibb Company

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Novartis AG

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GlaxoSmithKline

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Pharmascience Inc.

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Farmabios SPA

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 AdvaCare Pharma

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix

LIST OF TABLES

Table 1 Cortisone shots Industry Synopsis, 2020-2027

Table 2 Global Cortisone shots Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Cortisone shots Market by Region, 2020-2027, (USD Million)

Table 4 Global Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 5 Global Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 7 Global Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 8 North America Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 9 North America Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 11 North America Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 12 US Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 13 US Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 15 US Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 17 Canada Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 19 Canada Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 20 South America Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 21 South America Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 23 South America Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 25 Europe Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 27 Europe Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 29 Western Europe Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 31 Western Europe Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 33 Eastern Europe Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 35 Eastern Europe Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 37 Asia Pacific Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 39 Asia Pacific Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 41 Middle East & Africa Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 43 Middle East & Africa Cortisone shots Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Cortisone shots Market

Figure 3 Segmentation Market Dynamics for Cortisone shots Market

Figure 4 Global Cortisone shots Market Share, by Type, 2020

Figure 5 Global Cortisone shots Market Share, by Indication, 2020

Figure 6 Global Cortisone shots Market Share, by End Users, 2020

Figure 7 Global Cortisone shots Market Share, by Region, 2020

Figure 8 North America Cortisone shots Market Share, by Country, 2020

Figure 9 Europe Cortisone shots Market Share, by Country, 2020

Figure 10 Asia Pacific Cortisone shots Market Share, by Country, 2020

Figure 11 Middle East & Africa Cortisone shots Market Share, by Country, 2020

Figure 12 Global Cortisone shots Market: Company Share Analysis, 2020 (%)

Figure 13 Merck & Co., Inc.: Key Financials

Figure 14 Merck & Co., Inc.: Segmental Revenue

Figure 16 Merck & Co., Inc.: Geographical Revenue

Figure 17 Pfizer: Key Financials

Figure 18 Pfizer: Segmental Revenue

Figure 19 Pfizer: Geographical Revenue

Figure 20 Bristol-Myers Squibb Company: Key Financials

Figure 21 Bristol-Myers Squibb Company: Segmental Revenue

Figure 22 Bristol-Myers Squibb Company: Geographical Revenue

Figure 23 Novartis AG: Key Financials

Figure 24 Novartis AG: Segmental Revenue

Figure 25 Novartis AG: Geographical Revenue

Figure 26 Merck & Co., Inc: Key Financials

Figure 27 Merck & Co., Inc: Segmental Revenue

Figure 28 Merck & Co., Inc: Geographical Revenue

Figure 29 GlaxoSmithKline: Key Financials

Figure 30 GlaxoSmithKline: Segmental Revenue

Figure 31 GlaxoSmithKline: Geographical Revenue

Figure 32 Pharmascience Inc.: Key Financials

Figure 33 Pharmascience Inc.: Segmental Revenue

Figure 34 Pharmascience Inc.: Geographical Revenue